LISA ZAMPINI: Open Payments
NPI 1619121100 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 27 payments from 9 companies in 2025. Trend: 2023 $46 · 2024 $0 · 2025 $890
Food & beverage: $818Education: $73
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $289 |
| ABBVIE INC. | 7 | $213 |
| E.R. Squibb & Sons, L.L.C. | 1 | $109 |
| Neurocrine BioSciences, Inc. | 4 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $60 |
| Lundbeck LLC | 2 | $40 |
| Corium, LLC | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $18 |
Products named: VRAYLAR, AUSTEDO XR, COBENFY, INGREZZA, UZEDY, CAPLYTA, REXULTI, Azstarys.
Industry payments across NY — which companies pay providers there.
